FDA Inspection 1043453 — Octapharma plasma Inc.
The FDA completed an inspection of Octapharma plasma Inc. on March 1, 2018 in Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 1, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Columbia, SC (United States)